Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Intestinal Neoplasms × Polyethylene Glycols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 6 Inflammatory Bowel Diseases 3 Colonic Polyps 3 Colonic Neoplasms 3 Surgical Wound Infection 2 Neoplasms 2 Melanoma 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Rectal Neoplasms 1 Polyps 1 Ovarian Neoplasms 1 Opioid-Induced Constipation 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Intestinal Neoplasms 1 Gastrointestinal Hemorrhage 1 Diverticulitis 1 Cancer Pain 1 Adenoma 1

Interventions

Irinotecan 7 Bevacizumab 7 Leucovorin 6 Fluorouracil 6 Oxaliplatin 3 Capecitabine 3 Radiotherapy 2 Levoleucovorin 2 Drug Therapy 2 Bisacodyl 2 Aspirin 2 Artesunate 2 5,10-methylenetetrahydrofolic acid 2 trametinib 1 spartalizumab 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 nazartinib 1 napabucasin 1 guadecitabine 1 encorafenib 1 canakinumab 1 camrelizumab 1 apatinib 1 XELOX 1 Ursodeoxycholic Acid 1 Trastuzumab 1 Simvastatin 1 Polyethylene Glycols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01887158 2014-06-17

PEGOP

Ospedale Santa Maria delle Croci

Phase 4 Completed

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡